EPISODE · Oct 4, 2013 · 12 MIN
False Biomarker Discovery Due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125
from Clinical Chemistry Podcast
The discovery phase of proteomics is critical in the identification of suitable markers for exploration and validation of promising new clinical tests. But can laboratories be certain if what they believe they are measuring is, in fact, what they actually measuring?
Embed this episode
NOW PLAYING
False Biomarker Discovery Due to Reactivity of a Commercial ELISA for CUZD1 with Cancer Antigen CA125
0:00
12:06
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Clinical Chemistry Podcast?
This episode is 12 minutes long.
When was this Clinical Chemistry Podcast episode published?
This episode was published on October 4, 2013.
Can I download this Clinical Chemistry Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!